Simon Says

By: Business RadioX ®
  • Summary

  • Al Simon of Sandler Training by Simon interviews local business owners and sales professionals about some of the sales challenges they face and things they can do to increase sales for their organizations.
    © 2024 Business Radio X
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • SIMON SAYS, LET’S TALK BUSINESS: Chris Lindenau with Fusus
    Mar 23 2023
    Chris Lindenau/Fusus Fusus is the most widely used and trusted real-time crime center platform in U.S. Law Enforcement. The Fusus platform is an open ecosystem that integrates and enhances all public safety and investigations assets. It can integrate with any data source, pull in public and private video feeds, enable video sources with artificial intelligence, […] The post SIMON SAYS, LET’S TALK BUSINESS: Chris Lindenau with Fusus appeared first on Business RadioX ®.
    Show More Show Less
    Less than 1 minute
  • SIMON SAYS, LET’S TALK BUSINESS: Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners
    Feb 16 2023
    Tim Yoder/Duratec Roofing Solutions Duratec Roofing Solutions is a commercial roofing company specializing in the coatings and restoration industry along with single-plys. Located in Monticello, GA they service all of Georgia and surrounding states. Their goal is to provide service and quality for long lasting customer relationships. Jean-Christophe (J.C.) Laurent/Penon Partners Penon Partners is […] The post SIMON SAYS, LET’S TALK BUSINESS: Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners appeared first on Business RadioX ®.
    Show More Show Less
    Less than 1 minute
  • SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax
    Jan 19 2023
    David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […] The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
    Show More Show Less
    Less than 1 minute

What listeners say about Simon Says

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.